Abstract:OBJECTIVE:To observe effect of prescriptions replenishing vital essence, tonifying Qi and activating blood on expression of tumor necrosis factor-alpha (TNF-alpha) and interleukin-IP (IL-1beta) in serum and submaxillary gland of non-obese diabetic (NOD) mice with Sjogren's syndrome.METHOD:Thirty-two NOD mice were divided into four groups at random: the model group, the traditional Chinese medicine (TCM) group, the hydroxychloroquine group, the TCM and western medicine (WM) group, with 8 mice in each group. Eight Balb/C mice were taken as the normal normal control group. The TCM group was orally administered with 0.4 mL decoction replenishing vital essence, tonifying Qi and activating blood (100 g x kg(-1)) everyday; the hydroxychloroquine group were given 0.4 mL hydroxychloroquine (60 mg x kg(-1)) everyday; the TCM WM group were given 0.4 mL decoction, replenishing vital essence tonifying Qi and activating blood (50 g x kg(-1)) and hydroxychloroquine (60 mg x kg(-1)) everyday. Mice were sacrificed after eight weeks, and their arterial blood and tissues of submaxillary gland were collected. The levels of TNF-alpha, IL-1beta in serum were detected by ELISA. Expressions of TNF-alpha, IL-1beta protein in submaxillary gland were detected by immunohisto-chemistry.RESULT:Compared with other groups, TNF-alpha, IL-1beta in serum and submaxillary gland in the model group were higher (P < 0.05). The normal group showed lower serum TNF-alpha level than other groups (P < 0.05), but without statistical significance compared with the TCM group. IL-1beta in serum in the TCM group and the TCM WM group were lower than that of the hydroxychloroquine group (P < 0.05), but without statistical significance compared with the normal group. TNF-alpha protein expression in the TCM group and the TCM WM group showed no significant difference compared with the normal group, whereas the TCM WM group were notably lower than that of the hydroxychloroquine group (P < 0.05). IL-1beta expression in the TCM WM group showed no significant difference compared with the normal group.CONCLUSION:The decoction replenishing vital essence, tonifying Qi and activating blood can decrease the levels of TNF-alpha, IL-1beta in serum and submaxillary gland of NOD mice with Sjogren's syndrome. It may improve pathological damage of submaxillary gland by regulating Th1/Th2 cell factors, in order to achieve the therapeutic effect on SS.

The Exprassion and the Significance of NF-κB in the Sjgren's Syndrome

Local and Systemic IKKε and NF-κB Signaling Associated with Sjögren's Syndrome Immunopathogenesis.

[Effect of Prescriptions Replenishing Vital Essence, Tonifying Qi and Activating Blood on TNF-alpha, IL-1beta Expressions in Serum and Submaxillary Gland of NOD Mice with Sjogren's Syndrome].

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Act1 expression and its possible regulatory mechanisms in Sj(o)gren's syndrome

Increased Expression of the lncRNA NRON Along With NFATc1/PIM-1 in Labial Salivary Glands of Sjögren's Syndrome Patients

Expression and Significance of Matrix Metalloproteinase in Labial Salivary Glands of Patients with Sjgren's Syndrome

Expression Levels and Clinical Significances of BAFF, MMP-9 and E-cad in Labial Gland Tissues of Patients with Primary Sjogren's Syndrome

Expression of osteopontin in labial salivary glands in patients with Sjogren's syndrome

Immunophenotypes and clinical features of lymph ocytes in labial gland of patients with primary Sj(o)gren's syndrome

[Expression and DNA Binding Activity of NF-kappaB in Mucosal Tissue of Chronic Rhinosinusitis].

Expression and Significance of Nuclear Factor-κB in Ulcerative Colitis

Expression of FcγRⅡb on peripheral B cells and its clinical significance in patients with primary Sj(o)gren's syndrome

[Expression of Osteopontin in Labial Glands of Patients with Primary Sjögren's Syndrome].

Abnormal expression of IκBα during viral transactivation of transcription in steroid responsive simple nephrotic syndrome

Expressions and Clinical Significances of SSA Antibody, SSB Antibody and SS56 in Labial Gland Tissues of Patients with Sjogren's Syndrome

[Expressions and Clinical Significance of OX40 and OX40L in Peripheral Blood of Patients with Primary Sjogren's Syndrome].

Clinical Significance of the Expression Levels of Serum Transforming Growth Factor-Β and CXC Type Chemokine Ligand 13 in Primary Sjogren's Syndrome Patients.

Expression and significance of IKK,IκB and NF-κB in NSCLC

Expression of BAFF/BAFF-R in labial salivary glands/peripheral blood and its significance in Sj(o)gren's syndrome patients

Expression of osteopontin and other cytokines in serum in Sjogren's syndrome patients